Methylphenobarbital: Difference between revisions
CSV import |
CSV import |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description| | {{Short description|A barbiturate derivative used as an anticonvulsant}} | ||
}} | |||
'''Methylphenobarbital''', also known as '''mephobarbital''', is a [[barbiturate]] derivative that is primarily used as an [[anticonvulsant]] | [[File:Methylphenobarbital.svg|thumb|right|Chemical structure of Methylphenobarbital]] | ||
'''Methylphenobarbital''', also known as '''mephobarbital''', is a [[barbiturate]] derivative that is primarily used as an [[anticonvulsant]] in the treatment of [[epilepsy]]. It is a [[central nervous system]] [[depressant]] and has [[sedative]] and [[hypnotic]] properties. | |||
==Pharmacology== | ==Pharmacology== | ||
Methylphenobarbital is a [[GABA receptor]] agonist, which | Methylphenobarbital is a [[GABA receptor]] agonist, which enhances the inhibitory effects of [[gamma-aminobutyric acid]] (GABA) in the brain. This action helps to stabilize neuronal activity and prevent the excessive firing of neurons that can lead to [[seizures]]. | ||
==Medical uses== | ==Medical uses== | ||
Methylphenobarbital is primarily used in the | Methylphenobarbital is primarily used in the management of [[epilepsy]], particularly in the control of [[generalized tonic-clonic seizures]] and [[partial seizures]]. It may also be used in the treatment of [[anxiety]] and [[insomnia]] due to its sedative effects. | ||
==Side effects== | ==Side effects== | ||
Common side effects of methylphenobarbital include [[drowsiness]], [[dizziness]], and [[ataxia]]. Long-term use can lead to [[tolerance]] and [[dependence]]. | Common side effects of methylphenobarbital include [[drowsiness]], [[dizziness]], and [[ataxia]]. Long-term use can lead to [[tolerance]] and [[dependence]], and abrupt discontinuation may result in [[withdrawal symptoms]]. | ||
==Mechanism of action== | ==Mechanism of action== | ||
Methylphenobarbital | Methylphenobarbital works by enhancing the activity of GABA, the primary inhibitory neurotransmitter in the central nervous system. By increasing GABAergic activity, it helps to reduce neuronal excitability and prevent seizures. | ||
==Synthesis and metabolism== | ==Synthesis and metabolism== | ||
Methylphenobarbital is metabolized in the | Methylphenobarbital is metabolized in the liver to [[phenobarbital]], which is also an active anticonvulsant. This conversion contributes to its prolonged duration of action. | ||
== | ==Legal status== | ||
Methylphenobarbital | Methylphenobarbital is a controlled substance in many countries due to its potential for abuse and dependence. It is classified under various schedules depending on the jurisdiction. | ||
==Related pages== | ==Related pages== | ||
* [[Barbiturate]] | * [[Barbiturate]] | ||
* [[Anticonvulsant]] | |||
* [[Epilepsy]] | |||
* [[Phenobarbital]] | * [[Phenobarbital]] | ||
[[Category:Barbiturates]] | [[Category:Barbiturates]] | ||
[[Category:Anticonvulsants]] | [[Category:Anticonvulsants]] | ||
[[Category: | [[Category:GABAA receptor positive allosteric modulators]] | ||
Latest revision as of 10:54, 23 March 2025
A barbiturate derivative used as an anticonvulsant
Methylphenobarbital, also known as mephobarbital, is a barbiturate derivative that is primarily used as an anticonvulsant in the treatment of epilepsy. It is a central nervous system depressant and has sedative and hypnotic properties.
Pharmacology[edit]
Methylphenobarbital is a GABA receptor agonist, which enhances the inhibitory effects of gamma-aminobutyric acid (GABA) in the brain. This action helps to stabilize neuronal activity and prevent the excessive firing of neurons that can lead to seizures.
Medical uses[edit]
Methylphenobarbital is primarily used in the management of epilepsy, particularly in the control of generalized tonic-clonic seizures and partial seizures. It may also be used in the treatment of anxiety and insomnia due to its sedative effects.
Side effects[edit]
Common side effects of methylphenobarbital include drowsiness, dizziness, and ataxia. Long-term use can lead to tolerance and dependence, and abrupt discontinuation may result in withdrawal symptoms.
Mechanism of action[edit]
Methylphenobarbital works by enhancing the activity of GABA, the primary inhibitory neurotransmitter in the central nervous system. By increasing GABAergic activity, it helps to reduce neuronal excitability and prevent seizures.
Synthesis and metabolism[edit]
Methylphenobarbital is metabolized in the liver to phenobarbital, which is also an active anticonvulsant. This conversion contributes to its prolonged duration of action.
Legal status[edit]
Methylphenobarbital is a controlled substance in many countries due to its potential for abuse and dependence. It is classified under various schedules depending on the jurisdiction.
